Press release
The global digital biomarkers market is projected to be worth over USD 22 billion by 2030, growing at a CAGR of 35.74%, claims Roots Analysis
Roots Analysis has announced the addition of “Digital Solutions for Biomarkers Market, 2021-2030” report to its list of offerings.
Digital solutions for biomarkers are modern solutions that are capable of generating, collecting, and tracking medical data. From this data, digital biomarkers that offer insights into anatomical, physiological, and molecular events, and even behavior-related patterns in humans, have been acknowledged as viable inputs to understand, track, monitor and / or predict health-related outcomes. In the current pandemic, medical professionals are trying to identify digital biomarkers that can facilitate the successful screening / diagnosis of COVID-19 patients, remotely.
To order this 270+ page report, which features 135+ figures and 140+ tables, please visit https://www.rootsanalysis.com/reports/digital-biomarkers-market.html
Key Market Insights
Over 45 digital solutions for biomarkers are currently available / under development
Over 70% of the aforementioned solutions are offered either as combinations of software applications and devices or as standalone software solutions, targeting more than 30 unique target indications.
Over 85% of digital solutions for biomarkers are intended for patient monitoring purposes
Such solutions are currently available / being developed to monitor various digital biomarkers associated with neurological disorders (22%), respiratory disorders (17%), and infectious disorders (15%). In fact, over 15% of these solutions are being extensively used for monitoring patients with COVID-19.
40 global events, focused on digital solutions for biomarkers, have been organized since 2016
Around 40% of these were conferences, involving more than 25 unique organizers. Close to 50% of such events have been / are being organized in the US.
Nearly USD 950 million invested by both private and public investors in this domain
~70% of the total capital raised by digital solutions for biomarkers developers was from venture capital funding, featuring the contributions of over 150 investors. In addition, over 65% was invested in companies focused on development of physiological / vocal digital biomarkers.
Partnership activity in this field has grown at a CAGR of over 60%, between 2016 and 2020
More than 65% of the reported deals were established in the last two years (since 2019), with the maximum activity being reported in 2020. Majority of the instances captured in the report were research and development agreements (24%) and product / technology integration agreements (15%). Further, more than 40% of these agreements have been signed for digital solutions for physiological biomarkers.
North America and Europe are anticipated to capture over 65% of the market share by 2030
The market in Asia-Pacific regions is anticipated to grow at a relatively faster pace (41.03%). In 2030, digital solutions capturing vocal biomarkers are likely to represent the largest market share, in terms of revenues from product sales (37%), followed by those intended to capture physiological biomarkers (32%) and idiosyncratic biomarkers (16%).
To request a sample copy / brochure of this report, please visit this https://www.rootsanalysis.com/reports/digital-biomarkers-market/request-sample.html
Key Questions Answered
Who are the leading players engaged in the development of digital solutions for biomarkers?
Which are the popular therapeutic areas where digital biomarkers are currently relevant?
What kind of global level events related to digital biomarkers, have been organized in the recent past?
What is the trend of capital investments in the digital biomarkers market?
Which partnership models are most commonly adopted by stakeholders in this industry?
What is the tole of big pharma players engaged in this domain?
How has the COVID-19 pandemic impacted the digital biomarkers market?
What are the opportunities available for digital solutions for biomarkers in emerging markets?
How is the current and future opportunity likely to be distributed across key market segments?
What are the anticipated future trends related to digital solutions for biomarkers market?
The USD 22.6 billion (by 2030) financial opportunity within the digital solutions for biomarkers market has been analyzed across the following segments:
Content of Solution
Software Application + AI Support
Software Application + Device
Standalone Software Application
Other Contents of Solutions
Purpose of Solution
Diagnosis
Early Screening
Monitoring
Predictive Insights
Type of Biomarker
Cognitive Biomarkers
Idiosyncratic Biomarkers
Physiological Biomarkers
Vocal Biomarkers
Other Biomarkers
Therapeutic Areas
Autoimmune Disorders
Cardiovascular Disorders
Infectious Disorders
Mental Health Problems
Neurological Disorders
Respiratory Disorders
Substance Use Disorders
Others
Business Model
Business to Business (Healthcare Providers, Payers, Employers and Pharmaceutical Companies)
Business to Consumer (Patients and Caregivers)
Key Geographical Regions
North America
Europe
Asia-Pacific
Middle East and North Africa (MENA)
Rest of the world
The report features inputs from eminent industry stakeholders, according to whom, digital biomarkers are soon likely to witness increased adoption given their broad scope of applications and the availability of technologies that enable such biological inputs to be remotely identified and processed. The report includes detailed transcripts of the discussions held with following industry experts:
Edouard Gasser (Co-Founder and Chief Executive Officer, Tilak Healthcare)
Michael Seggev (Chief Commercial Officer, Vocalis Health)
The research covers brief profiles of key players engaged in the development of digital solutions for biomarkers; other popular industry players featured in the report include:
Akili Interactive
AiCure
Cogito Corp
Janssen Pharmaceuticals
Huma
Mindstrong Health
Oura
Pear Therapeutics
Roche
Sonde Health
Vocalis Health
Winterlight Labs
For additional details, please visit
https://www.rootsanalysis.com/reports/digital-biomarkers-market.html
You may also be interested in the following titles:
1. AI-based Drug Discovery Market: Focus on Deep Learning and Machine Learning, 2020-2030
2. Connected / Smart Drug Delivery Systems Market by Product Type (Connected Inhalers, Connected Autoinjectors, Connected Pen injectors, Connected Wearable Injectors, Add-On Sensors and Others), Therapeutic Area (Metabolic Disorders, Neurological Disorders, Respiratory Disorders and Others) and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America, MENA and Rest of the World): Industry Trends and Global Forecasts, 2020-2030
3. Diabetes Monitoring Devices Market by Type of Device (Self-Monitoring Blood Glucose Devices and Continuous Blood Glucose Monitoring Devices), Diabetes Type (Type 1 Diabetes and Type 2 Diabetes), Type of Self-Monitoring Blood Glucose Device Component (Lancing Devices, Blood Glucose Meters and Testing Strips), Type of Continuous Blood Glucose Monitoring Device Component (Sensors, Transmitters and Receivers), and Key Geographies: Industry Trends and Global Forecasts, 2020-2030
Contact:
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com
Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The global digital biomarkers market is projected to be worth over USD 22 billion by 2030, growing at a CAGR of 35.74%, claims Roots Analysis here
News-ID: 2249795 • Views: …
More Releases from Roots Analysis
Antibody Discovery Market Set to Soar to $6.6 Billion by 2035
Antibodies, also known as immunoglobulins, are Y-shaped glycoproteins that are produced by the immune system in response to foreign molecules (antigens) that enter the body. The term antigen refers to any substance that is capable of inducing an immune response, encompassing a diverse range of entities, including viruses, fungi, bacteria, proteins on the surface of cells, and non-living substances, such as toxins, chemicals and foreign particles.
The global antibody discovery…
Biopsy is defined as a procedure of removing or extracting tissue from the body …
The global virtual biopsy market, valued at USD 0.73 billion in 2024, is projected to reach USD 0.78 billion in 2025 and USD 3.02 billion by 2035, representing a CAGR of 14.47% during the forecast period.
This procedure plays a crucial role in the diagnosis or monitoring of certain medical conditions such as inflammatory disorders, immune disorders, oncological conditions, and several infections. By analyzing the cellular composition of the extracted tissue,…
Big data in healthcare: transforms patient care, enhances efficiency, and unlock …
The global big data in healthcare market size is estimated to grow from USD 78 billion in 2024 to USD 540 billion by 2035, representing a CAGR of 19.20% during the forecast period till 2035. Big data in healthcare is the collection of large amounts of unstructured data from various sources, such as medical research, biometric data, electronic medical records, Internet of Medical Things (IoMT), social media, payer records, omics…
AI In Oncology Market CAGR to Exceed 14%, Due to The Growing Demand for Diagnosi …
With an aim to counter the rising number of cancer cases across the globe, artificial intelligence has emerged as the key enabler in cancer treatment to generate better clinical outcomes.
According to the World Health Organization (WHO), in the healthcare sector, oncology is one of the important sections primarily because cancer is the second leading causes of mortality worldwide. It is estimated that in 2022, about 1.9 million new cancer cases…
More Releases for Disorders
Bleeding Disorders Market Is Driven By Bleeding Disorders In Various Industries, …
The Bleeding Disorders Market is a critical component of the healthcare industry, focused on the diagnosis, treatment, and management of bleeding disorders that affect individuals' blood clotting mechanisms. These disorders, which include hemophilia, von Willebrand disease, and various clotting factor deficiencies, can lead to prolonged and spontaneous bleeding, posing significant health risks. This market encompasses a range of therapies, medications, and diagnostic tools designed to address the unique needs of…
Gene Therapy For Rare Disease Market By Therapeutic Application ( Oncology, Neur …
The Gene Therapy For Rare Disease Market report outlines the evolution of Gene Therapy For Rare Disease industry by type, applications and identifies and assesses the best performing vendors in the market till 2028. Gene Therapy For Rare Disease Market reports present the revenue opportunities in the Gene Therapy For Rare Disease industry through 2023-2028, highlighting the market size and growth by technology, geography, vertical and End users.
Download Sample PDF…
Neuroprosthetics Market 2019 Industry Segmentation by physiological disorders ar …
Neuroprosthetics Market 2019 Scenario
Neuroprosthetics Market was estimated to be USD 5.28 billion in 2016 and expected to reach USD 10.48 billion by 2023. The key factors responsible for driving this are increasing in geriatric population, auditory processing disorders in kids, and increase in spinal cord treatment due to advancement in neuroprosthetics devices.
The factors responsible for the positive growth of this market are increasing prevalence of neural diseases, over active bladder…
Global Vocal Biomarker Market to Experience Significant Growth during the Foreca …
Vocal patterns have been used by clinical psychologists and psychoanalysts for analyzing personality traits of patients, and helping creation of headway in clinical and medical investigations. Recent breakthroughs in the healthcare sector have led to the development of a unique diagnostic tool known as Vocal Biomarker Market by combining the concept of biological markers with the aforementioned methodology to analyze personality traits.
Claim Sample Report For FREE: https://www.factmr.com/connectus/sample?flag=S&rep_id=719
These vocal biomarkers are…
Behavioral Therapy Market Report 2018: Segmentation by Type (Anxiety Disorders, …
Global Behavioral Therapy market research report provides company profile for American Addiction Centers, ChanceLight, Haven Behavioral Healthcare, Behavioral Health Group, Center for Autism & Related Disorders, People’s Care, Magellan Health, Universal Health Services, Acadia Healthcare, Springstone and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY…
Biopharmaceuticals Market Outlook 2025|( Biopharmaceuticals Application:- Infect …
Global Biopharmaceuticals Market Research Report Brief Focus On Study About Biopharmaceuticals Market Industry volume, Market Revenue, Market Segments , Market Trends ,Growth aspects A wide range of applications, Utilization ratio, Supply and demand analysis are also consist in the report such as:
Biopharmaceuticals Product Type:- Monoclonal Antibodies, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Synthetic Immunomodulators, Vaccines,
Biopharmaceuticals Application :- Inflammatory , Infectious Diseases, Autoimmune Disorders, Metabolic…
